CERo Therapeutics Inc. (CERO)
NASDAQ: CERO
· Real-Time Price · USD
7.97
-0.14 (-1.73%)
At close: Aug 15, 2025, 3:59 PM
7.89
-1.07%
After-hours: Aug 15, 2025, 07:49 PM EDT
CERo Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | -10.1M | -7.29M | -6.52M | -5.37M | -5.01M | -5.15M | -5.13M | -4.71M | -2.73M | -667.74K | -719.61K | -804.11K | -692.54K | -314.55K | n/a |
Depreciation & Amortization | 1.14M | 1.16M | 878.75K | 581.41K | 565.61K | 551.03K | 551.03K | 551.03K | 273.58K | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | -1.1M | -1.4M | 1.9K | 25K | 50.88K | 78.92K | 78.92K | 55.42K | 28.14K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 144.31K | -474.57K | 402K | 629.1K | -103.53K | 700.94K | 1.95M | 2.41M | 2.44M | 2.35M | 532.82K | -129.52K | -269.39K | -366.08K | n/a |
Other Non-Cash Items | 4.21M | 2.04M | -3.69M | -4.35M | -1.95M | 727.68K | -724.76K | -1.58M | -2.3M | -2.84M | -1.29M | -308.27K | -43.26K | -16.48K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 640.35K | -265.01K | -749.6K | 77.6K | -534.3K | 1.03M | 2.28M | 2.8M | 2.98M | 2.41M | 593.28K | -129.52K | -269.39K | -366.08K | n/a |
Operating Cash Flow | -3.84M | -4.47M | -8.81M | -9.06M | -7.6M | -3.95M | -4.14M | -4.06M | -2.22M | -1.09M | -1.42M | -1.24M | -1.01M | -697.11K | n/a |
Capital Expenditures | -4 | -6 | -2 | -2 | -2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -13.89M | -13.89M | -13.89M | -13.89M | -325K | -325K | -325K | -325K | -178.5M | -178.5M | -178.5M | -178.5M | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | 5.08M | 5.08M | 5.08M | 5.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 73.31K | 752.3K | 1.04M | 1.04M | 182M | 181.45M | 181.16M | 181.16M | 128.49K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -185.24K | -185.24K | -14M | -8.13M | -7.84M | -7.84M | 186.68M | 181.12M | 180.84M | 180.84M | -178.37M | -178.5M | -178.5M | -178.5M | n/a |
Debt Repayment | -280.52K | -300.24K | -319.95K | -169.06K | 585.51K | 605.23K | 605.23K | 605.23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -27.84M | -33.48M | -33.48M | -33.48M | -144.99M | -139.35M | -139.35M | -139.35M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3.59M | -9.18M | 178.81K | 396.32K | 355.01K | 346.45K | 837.33K | 617.33K | 656.04K | 650.88K | 180.3M | 180.3M | 180.3M | 180.3M | n/a |
Financial Cash Flow | 2.23M | 3.06M | 12.21M | 4.3M | 2.28M | -4.87M | -143.55M | -138.13M | -138.7M | -138.7M | 180.3M | 180.3M | 180.3M | 180.3M | n/a |
Net Cash Flow | 2.43M | 5.05M | 5.05M | 1.27M | 709.43K | -5.22M | 37.38M | 38.65M | 39.92M | 41.04M | 507.92K | 553.77K | 790.48K | 1.1M | n/a |
Free Cash Flow | -5.16M | -5.79M | -10.12M | -9.06M | -7.6M | -3.95M | -4.14M | -4.06M | -2.22M | -1.09M | -1.42M | -1.24M | -1.01M | -697.11K | n/a |